Stellbrink, Hans-Jürgen - Search Results - UAB Digital Repository of Documents

Search collections:

Sort by:	Display results:	Output format:

Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found

Articles	2 records found

12 p, 608.0 KB

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk / Gatell, José Mª (Hospital Clínic i Provincial de Barcelona) ; Assoumou, Lambert (UPMC Univ Paris 06) ; Moyle, Graeme (St Chelsea and Westminster Hospital) ; Waters, Laura (Mortimer Market Center) ; Johnson, Margaret (Royal Free Hospital) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Fox, Julie (Guys and St. Thomas Hospital) ; Martinez, Esteban (Hospital Clínic i Provincial de Barcelona) ; Stellbrink, Hans-Jürgen (ICH Study Centrum) ; Guaraldi, Giovanni (University of Modena and Reggio Emilia) ; Masia, Mar (Hospital General Universitario de Elche) ; Gompels, Marl (Southmead Hospital) ; De Wit, Stephane (Université Libre de Bruxelles) ; Florence, Eric (Institute of Tropical Medicine) ; Esser, Stefan (Universitatsklinikum) ; Raffi, François (CHU de Nantes) ; Pozniak, Anton L. (St Chelsea and Westminster Hospital) ; Universitat Autònoma de Barcelona
To compare the efficacy, safety, and impact on lipid fractions of switching from a ritonavir-boosted protease inhibitor (PI/r) to a dolutegravir (DTG) regimen. HIV type 1-infected adults more than 50 years or with a Framingham score more than 10% were eligible if plasma HIV RNA less than 50 copies per ml for at least 24 weeks while on a PI/r regimen. [...]
2017 - DOI (Digital Object Identifier)

10.1097/QAD.0000000000001675
AIDS, Vol. 31 Núm. 18 (28 2017) , p. 2503-2514

Detailed record -

7 p, 214.7 KB

Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression / Llibre, Josep M. (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ; Cozzi-Lepri, Alessandro (University College London, UK) ; Pedersen, Court (Odense University Hospital (Dinamarca)) ; Ristola, Matti (Helsinki University Hospital (Finlàndia)) ; Losso, Marcelo (Hospital General de Agudos JM Ramos Mejía, Buenos Aires, Argentina) ; Mocroft, Amanda (University College London, UK) ; Mitsura, Viktar (Gomel State Medical University, Belarus) ; Falconer, Karolin (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Maltez, Fernando (Curry Cabral Hospital, Lisboa, Portugal) ; Beniowski, Marek (Specialistic Hospital, Chorzów, Poland) ; Vullo, Vincenzo (Policlinico Umberto 1, Rome, Italy) ; Hassoun, Gamal (Rambam-Health Care Campus, Haifa, Israel) ; Kuzovatova, Elena (Nizhny Novgorod Scientific and Research Institute of Epidemiology and Microbiology named after Academician I.N. Blokhina, Russia) ; Szlavik, János (St László Hospital (Hongria)) ; Kuznetsova, Anastasiia (Kharkov State Medical University, Ukraine) ; Stellbrink, Hans-Jürgen (ICH Study Center, Hamburg, Germany) ; Duvivier, Claudine (APHP-Hôpital Necker-Enfants Malades, Paris, France) ; Edwards, Simon (Mortimer Market Centre, UK) ; Laut, Kamilla (Centre for Health & University of Copenhagen, Denmark) ; Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa)
Effectiveness data of an unboosted atazanavir (ATV) with abacavir/lamivudine (ABC/3TC) switch strategy in clinical routine are scant. We evaluated treatment outcomes of ATV + ABC/3TC in pretreated subjects in the EuroSIDA cohort when started with undetectable plasma HIV-1 viral load (pVL), performing a time to loss of virological response (TLOVR <50 copies/mL) and a snapshot analysis at 48, 96, and 144 weeks. [...]
2016 - DOI (Digital Object Identifier)

10.1097/MD.0000000000005020
Medicine, Vol. 95, Num. 40 (october 2016)

Detailed record -

See also: similar author names
1	Stellbrink, H.J.

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.